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SERS based immunoassays for point-of-care diagnostics is a promising tool to facilitate
biomarker detection for early disease diagnosis and control. The technique is based on a
sandwiched system in which antigen is first captured by a selective substrate and then labeled by
an extrinsic Raman label (ERL). Here, we report on the use of gold nanoparticle modified filter
paper as a novel capture membrane in a vertical flow format. This vertical flow configuration
affords reproducible flow of sample and label through the capture substrate to overcome
diffusion limited kinetics and significantly reduced assay time. The filter paper was selected due
to its affordability and availability, while the embedded AuNPs maximized plasmonic coupling
and SERS enhancement. Additionally, the embedded AuNP served as a scaffold to immobilize
capture antibody to specifically bind antigen. In this work, a SERS-based rapid vertical flow
(SERS-RVF) immunoassay for detection of mouse IgG was developed to establish proof of
principle. Optimization of assay conditions led to a limit of detection of 3 ng/mL, which is
comparable to more traditional formats carried out in multi-well plates and significantly reduced
assay time to less than 2 minutes. Additionally, IgG was accurately quantified in normal serum
to validate the SERS-RVF assay for application to the analysis of biological samples. These
results highlight the potential advantages of the SERS-RVF platform for point-of-need testing.

KEYWORDS: Immunoassay; surface-enhanced Raman scattering (SERS); plasmonic paper;
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CHAPTER I: INTRODUCTION
Significance of Study
The health and well-being of a nation’s labor force determine the long-term social and
economic stability of that nation. The world health and technology has seen many improvements
the last 50 years [1]. However, there is still more to do as millions die each year in populated
countries due to infectious diseases like malaria, AIDS and tuberculosis. These deaths are
sometimes due to the challenge of easy treatment options such as in developed countries. Ability
to precisely diagnose diseases at their onset of development is a key to determining the origin of
the disease. Research proves that the inability to rapidly diagnose diseases which are treatable
and preventable at their early stage accounts for the progressive increase in the number of deaths
especially in the low- and middle-income countries [1, 2].
Recent improvement in the disease diagnosis has been focusing on early detection of
disease to efficiently provide good medication in order to control the passing pace of patients.
For some time now, many healthcare practitioners have been relying on sophisticated laboratorybased procedures to diagnose disease which has the limitation of long analysis time and requires
expertise to generate results. The current advancement and development in the disease diagnosis
has been focusing on point-of-care testing (POCT). POCT is the integral part of medicine, it
enables simple automated testing that yield fast results.

Point-of-Care Testing
POCT refers to diagnostic test that is performed in proximity of patients where medical
attention is needed to diagnose, monitor and control disease [3, 4]. The test is typically
performed by doctors, laboratory personal or patients. Samples such as blood are collected from
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the patients and analyzed. POCT devices offer advantage of rapid diagnosis of the disease,
minimal sample volume for testing portability and cost effectiveness. POCT are normally used in
hospitals, paramedic support vehicles and many other environments [5]. The ability of a POCT
device to selectively extract and detect the disease biomarker from the patient sample’s matrix
such as the serum, blood and urine and provide results within a short time makes it an attractive
in the diagnostic arena. The demand for POCT devices has been increasing due to the
corresponding global increase of chronic and infectious diseases.
Currently, there have been huge investments in the field resulting in a high value of the
global POCT market [6], which was estimated at $13.87 billion in 2017 and is estimated to grow
over $23.92 billion by 2026 [7]. Recently, there have been enormous research publications
aiming to improve the current POCT. The majority of these publications have been focused on
increasing sensitivity, affordability and simplicity of the device. The most common POCT
platforms are based on lab-on-a-chip [8], paper [9], microfluidics [10] and novel assay formats
[11, 12].

Immunoassay and its Application
The advancement in complementary technologies and the continuous improvements play
a vital role in development of next-generation POCT technologies. One key area that is gaining
much attention for development of point-of-care testing is the immunoassay, which has been
extensively utilized from basic research science to clinical settings, due primarily to the
specificity of antibodies for their molecular antigen counterparts.
Immunoassay refers to a test in which responses are based on the interactions between
antibody and antigen (analyte) and are commonly relied on for the diagnosis of many infectious
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diseases [13, 14]. The technique was developed by Rosalyn Sussman Yallow in 1950 which
resulted in the Nobel Prize in 1977 [15]. The technique offers several advantages such as
inexpensive testing, high sensitivity, high selectivity and can be applied to various targets. The
most common applications include drug testing [16], hormone testing [17, 18], bacterial or viral
testing [19, 20] and environmental testing [21, 22].
The main principle of immunoassays is based on the ability of the antibody to recognize
and bind to specific antigen to form an antibody-antigen complex also refers to as an
immunocomplex. This complex formation is then separated from the unbound antigens through a
series of washing steps and are detected by measuring the activity of a label that is covalently
link to either antibody or antigen depending on the interest of the assay. Immunoassays have
been used in various applications and there have been many research publications to improve the
field [20, 21, 23, 24].

Formats of Immunoassay
Immunoassays come in two main forms: heterogeneous and homogeneous. In the case of
heterogeneous, either the antibody or antigen is immobilized on a solid support (for example test
tubes, microplates, latex beads, filter paper or magnetic particles) followed by washing to
remove any unbound material [15]. The heterogeneous immunoassay comes in competitive and
noncompetitive formats, the noncompetitive format is displayed in Figure 1a [25]. Here, the
antigen sample is incubated with an excess of antibody reagent. All the antigen molecules
become bound, but not all the antibody binding sites are occupied. To detect the amount of
antigen attached to an antibody, a second, labelled antibody is added which binds to another
epitope of the antigen. This leads to formation of a sandwich-complex between the primary
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antibody, the sample antigen and the labelled secondary antibody. After washing off any excess
reagent, the sandwich-complexes containing the label can be detected and the signal generated is
directly related to the amount of antigen in the sample. The response of this type of format is
displayed in Figure 1b [25]. The labelled secondary antibody binds directly to the target antigenantibody complex. So, the larger the number of sample molecules, the larger the signal, but with
very high or low concentration the curve flattens out [30]. Heterogeneous immunoassays are
used in most environmental and clinical applications as a result of the complex samples typically
encountered. A good example of application of this format is HIV-antibody detection [26, 27] .
In a homogeneous immunoassay format, there are no separation steps of the
immunoreagents which sometimes results in matrix interferences.

(a)

Antigen Binding

Immobilized Antibody

4

Non competitive assay response
Signal
Intensity

(b)

Change of Concentration

Figure 1. Immunoassay formats (a) Non-competitive (b) Response of non-competitive

Antibodies and its Structural Activities
Antibodies, also referred to as immunoglobins, are proteins that are essential in the
immune system. They recognize and neutralizes pathogens or antigens (Ag) (proteins,
polysaccharides, nucleic acids) that invade the body and stimulate the production of
immunoglobins. Antibodies have been used in various biosensor platforms including
electrochemical [28], fluorescent [29] and colorimetric assays [30]. There are two main types of
antibodies that are used in immunoassay, monoclonal or polyclonal. Monoclonal antibodies bind
only one single binding site (epitope) on the antigen, while the polyclonal antibodies are able to
bind to different sites (epitopes) of the same antigen. The use of monoclonal antibodies has the

5

advantage of less cross-reactivity due to its specificity to one binding site than the polyclonal,
however, many biosensors make use of polyclonal due to its low cost of production.
Immunoglobin G (IgG) has a general structure which consists of a distinctive Y-shape
and are composed of two heavy chains and two light chains as shown in the Figure 2. These
chains are held together by disulfide bonds. The regions that bind to pathogens are located at the
tips of the two arms formed by heavy and light chain domain called hypervariable region. The
hypervariable region also referred to as Fab or paratope ends with the NH3+ terminal of amino
acid that binds to the epitope (binding site of antigens). The Fab of each antibody is unique and
allows the antibody to interact with a specific antigen. The antibody and antigen interact in a
lock and key manner. This unique feature of the antibody explains the selectivity and specificity
of immunoassays and their value for the detection of diseases. There are five types of antibodies
found in human and other mammals. Thus IgG, IgM, IgA, IgD and IgE, the most abundant one is
the IgG. The IgG types have a molecular weight of approximately 150 kDa. Each type has
different shape and size.
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Figure 2. Structure of immunoglobin G (IgG). Red variable region of light and heavy chain for
antigen binding site and grey constant region that has heavy and light chain.

Established Immunoassay Formats
The complex formation of the immunochemical reaction between the antibody and
antigen serve as the basis of the immunoassay. They may be visualized or detected by measuring
the activities of the label used. The type of label will determine the format of the immunoassay
assay and the method of detection. Several prominent assay formats have been developed during
the last two decades for highly prospective POCT. A recent review has provided a summary of
the various detection methods with different advantages and limitations [31]. Labels and
detection techniques such as fluorescence polarization [32], chemiluminescence [33],
electrochemical detection [34] and surface enhanced Raman spectroscopy (SERS) [35], as well
as more novel labels, have also been explored to enhance the detection of trace analytes [36].
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The current method of detection that is employed as standard diagnostic platforms are
the enzyme-linked immunosorbent assay (ELISA) [26, 30, 37] and the lateral flow assay (LFA)
[38, 39]. ELISA uses enzyme labels such as alkaline phosphatase and horseradish peroxidase on
the secondary antibody providing a colored end product. In one form of ELISA, sample
containing the antigen is added to a well plate which is coated with the antigen-specific antibody
and then incubated for several hours. After incubation a series of washing is done to remove
excess unbound antigens, then an enzyme label antibody is added followed by the addition of
substrate which results in the formation of a colored product. The quantity of the antigen present
is quantified by measuring the absorbance of the colored product. Figure 3 illustrates the ELISA
process. ELISA offers quantitative information but it is a time-consuming multistep process [40].
LFA has also been used as an alternative to reduce turnaround time by providing rapid
results for several analyses [41]. LFA makes use of a nitrocellulose membrane test strip which
allows samples to flow laterally through the strip by the action of capillary force provided by
absorbent pads. Here the sample is applied on a sample pad and begins to flow laterally over the
conjugate pad where the analyte binds with the conjugate’s particles. Figure 4 details the process
of LFA [38]. LFA is rapid and simple technique which is used as a point-of-care diagnostic by
healthcare professionals, patients and individuals. LFA has been extensively utilized for various
analysis, for example, the most widely used pregnancy tests are based on the LFA principle
where the human hormone chorionic gonadotropin (hCG) in urine is detected [42]. LFAs have
also been develop for the detection of cancer biomarkers [43], HIV diagnosis [44, 45] and
nucleic acid testing [46, 47]. Despite the importance of this platform, it also comes with several
limitations including poor limit of detection [48]. According to reports from Hurt et al [49], LFA
was used in population screening of people infected with influenza virus using the commercially
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available products Binax Now Flu A&B, BD Directigen EZ Flu A+B, Rockedby influenza A and
Quidel Quickvalue Flu A+B. The LFAs only identified 73%, 69%, 10% and 67% respectively of
the know positive cases [49]. Recently, rapid vertical flow (RVF) assays have been explored as
an alternative to LFAs in an effort to reduce the false negative rates and provide even faster
analysis [50, 51].
Given these limitations, there has been several reports on ways to improve the uses of
these conventional flow assay platforms, with majority of them focusing on enhancing the
sensitivity using novel detection modalities such as surface plasmon resonance (SPR) [52],
nanowires [53], and quantum dots [54]. However, each of these improvements sacrifices the
simplicity, precision and low cost of POCT. An alternative to these detection modalities is
SERS. The exceptional properties of SERS such as high sensitivity, potential for multiplexed
detection, photostability, and portability allows it to be more useful than other techniques in the
diagnostic arena especially with the recent development of portable hand-held Raman
spectrometers [55].

Coated antibody

Sample incubation and
antigen binding

Labelled antibody binds
with captures antigen

Figure 3. Principle of enzyme linked immunosorbent assay.
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Addition of enzyme which
is converted into colored
product

(a)

(b)

(c)
Figure 4. Principle of lateral flow assay. (a) sample is applied to sample pad (b) sample bind
with conjugates and flow across by capillary force (c) conjugates are bind to immobilized
antibody at the test line to form a color and the control line indicates that.

Surface Enhanced Raman Spectroscopy (SERS)
Raman spectroscopy is a vibrational spectroscopy resulting from inelastic scattering of a
monochromatic light (e.g laser) by atoms of a molecule. Raman spectroscopy is widely used for
the analysis of biological materials such as proteins [56], DNA [57] and chromosomes [58]. The
molecular composition and the extent of atomic interactions contribute to the vibrational
spectrum of the molecule, which provides valuable information for identification and
quantification of the molecule. However, a large concentration of the analyte molecule is
required to enable the Raman spectroscopic analysis. This has been a major disadvantage to the
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use of Raman spectroscopy for the analysis of biological compounds which are present in small
quantities resulting in the generation of weak signal from the spectrum. Moreover, a high laser
power of about 300 mW is required which can cause damage to biological samples.
The limitation of Raman spectroscopy has been overcome through SERS. SERS is
defined as an analytical technique that is used to obtain the vibrational spectrum of molecules
adsorbed onto metallic nanostructures which provides large SERS active surface area for signal
enhancement. SERS has become more useful and has been found in many applications [59] due
to its ability to enhance the Raman signal by a factor of 1010 [60]. The SERS phenomenon is a
result of the energy changes of the light scattered by vibrating molecules adsorbed on a metallic
surface [61]. The factors contributing to SERS enhancement have been found to be chemical and
electromagnetic in nature [62].
The electromagnetic (EM) effect has been found to be the strongest contribution to the
SERS enhancement due to the strong vibration of the molecules experienced at the surface of the
metal particle. In the EM phenomenon, the electromagnetic wave of an incident laser impinges at
the metal and dielectric interfaces which energizes the delocalized conduction electrons of the
metal nanostructures into collective oscillation (Figure 5). When the frequency of the incident
light matches with the inherent oscillation frequency of free electrons in the metal, SPR occurs.
The magnitude of the SPR generated depends on the size, shape, electron density and dielectric
environment of the nanostructure [63]. The SPR that is generated is highly localized on the
metallic surface and is referred to as localized surface plasmon resonance (LSPR) and the
metallic substance is termed as plasmonic nanoparticle (PNP). During the enhancement process,
the LSPR generated at the surface of the PNP couples with the incident light’s resonance which
result to huge signal generation [63]. The magnitude of this enhancement has been determined to
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reach from 103 to 1010 [26]. This phenomenon has led to significant effort to improve the
analytical performance of SERS techniques. Today many articles [64, 65] and reviews [66, 67]
have been published, all aiming at controlling the size, structures and distance of the PNP to
provide reproducible fabrications of optimal conditions for highly sensitive analytical analysis.
The most common metals found to observe this phenomenon are gold and silver. Gold
has been preferred over silver in the analysis of biological compounds due to its longer excitation
wavelength (above 600 nm) and excellent biocompatibility [67].

Incident light
E-field
Electron cloud

Au

Au

Electron cloud
E-field

Figure 5. Electromagnetic effect of SERS. Incident light set the electron clouds into oscillation
to generate large local field, two NP at a closed proximity increased in oscillation due to
coupling of local electric field which enhanced signal.

SERS Hot Spots
Development of SERS technology to detect single molecules has been reported in several
papers [68, 69] and it has been found that aggregated nanoparticles produce higher enhancement
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than a single plasmonic nanoparticle [70, 71]. The enhancement contribution of the aggregated
nanoparticle has been attributed to the interparticle distance between two PNP that are brought to
closed proximity to each other. The space that is created by the two nanoparticles generates a
very high electric field (as shown by Figure 5) as a result of the interaction of the electron clouds
surrounding the particles and therefore produced an extremely strong SERS signal. The volume
of the space that creates this strong SERS signal is referred to as a SERS-hot spot [72, 73]. These
advantages have enabled various applications of SERS such as noninvasive chemical detection
and identification of biological molecules such as proteins [74] and DNAs [75].

Au

Au

Au

Figure 6. Illustration of SERS-hot spot (red). Generated due to decrease in interparticle distance.

SERS-Based Immunoassay
Recent developments of SERS-based immunoassays have been focused on increasing the
sensitivity of the SERS substrate for various applications [76, 77]. One area that has been
intriguingly successful and gaining much attention is PNP-enabled SERS immunoassay [76, 78].
The SERS active surface is fabricated by carefully arranging a gold nanoparticle array which
generates the localized surface plasmon resonances and the laser exposure to the analytic
biomolecules. The main focus of the SERS technology is to control the interparticle gap and
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diameter of the metal nanoparticles in order to generate SERS hot spots which increase the SERS
signal when analytic biomolecules are close to the SERS-active surface.
A recent report indicates that SERS hot spots can be generated when the interparticle
distance is less than 10 nm [79]. The detection of biomolecules using gold nanoparticle SERS
strategy has been used in various applications. For example, Wang et al. reported the use of
Raman label bound to an antibody-functionalized gold nanoparticle to indirectly detect rabbit
IgG [35]. Also, there have been SERS immunoassay reports on the quantitation of HIV-1 [45]
and staphylococcal enterotoxin [80].
Current developments in SERS-based immunoassays are focused on coupling SERS with
POCT immunoassay platforms. For example, Clark et. al reported on coupling SERS with RVF
for the detection of hepatitis C (HCV) biomarker using a nitrocellulose membrane as the capture
substrate [51], however their technique suffers from limited sensitivity because of non-coupling
of gold nanoparticles.
There have been several reports describing the plasmonic coupling in interacting AuNPs
and has been found that the enhancement generated from the nanoparticle gap increased as the
gap between the interacting nanoparticles decreases [81, 82]. Also, Wulstholz et al [97] reported
that the enhancement is independent of the cluster size and excitation wavelength and that SERS
enhancement increases with decreasing interparticle distance. Guerrini et al. also reported
through the use of DNA triplexes to control the interparticle distance in nanoparticle clusters in
suspension and found that the SERS enhancement correlated with nanoparticle gap distance
rather than cluster or plasmon band [83]. There are several other publications which support the
development of SERS as a quantitative analysis technique based on aggregation assays [84].
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Thus, a SERS-based immunoassay that capitalizes on these nanoparticle-nanoparticle
interactions would offer substantially improved sensitivity.
The SERS-based immunoassay consists of three main parts, the capture substrate, the
analyte (antigen to be detected) and a functionalized gold nanoparticle. The capture substrate
consists of a primary antibody immobilized on the surface of a support which selectively
captures the specific antigen from the sample solution. The analyte is the antigen within the
sample solution which is under investigation; they are usually macromolecules such as DNA or
protein. The third component is composed of a gold nanoparticle which has a secondary antibody
immobilized on its surface and is functionalized with a Raman reporter molecule in a system
called the extrinsic Raman-label (ERL).
The ERL is an essential part of the assay which is normally used as a tracer molecule in
the SERS-based assay to identify the presence of the analytes. The characteristic of the Raman
spectrum produced is determined by the Raman reporter molecule which is used to identify the
analytes. The narrow spectral width of the vibrational Raman band enables all SERS labels to be
simultaneously excited with a single laser which gives advantage for SERS to identify many
particles simultaneously. Examples of Raman labels used in SERS-immunoassays are 4nitrobenzenethiol (NBT) and para-aminothiophenol (p-ATP) [85].
There have been extensive on reports nanoparticle (NP) enabled SERS immunoassays for
bioanalytical applications, and they have been used for diagnostic applications [86]. The first
SERS-based immunoassay was developed by Ni et al. in 1999. Here, a glass slide was coated
with gold film and the antibody immobilized on it, analyte is then incubated with the antibody
and washed off excess reagents followed by adding the ERL and then washed again to remove
nonspecific binding. The sandwiched formation is then detected using SERS. The procedure is
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simple and sensitive but has long preparation time due to slow movement of large mass of
analytes (antigen) to bind with the antibody during incubation process, which can take overnight.
The ideal SERS-based immunoassay for point-of-care testing should be rapid, sensitive,
easy-of-use and affordable. The speed of immunoassay plays a vital role in the diagnostic arena
especially in a point-of-care testing. At the intensive care unit (ICU), POCT is used to diagnose
patients with various life-threatening conditions, and the faster the diagnosis the sooner the right
medical treatment response. Recent advancement in the field has been showing significant effort
to speed up the SERS-based immunoassay through various ways. Our group previously
developed a system using a syringe to facilitate the diffusional mass transport of analytes [87].
However, this technique also suffers from imprecision because of variable flow rate. A vertical
flow system which is fast and ensures a consistent flow of solution was reported by Clarke et al,
however, the technique is not sensitive due to non-coupling of nanoparticles [51].
An assay format that is highly sensitive to diagnosis trace amounts of analytes is on high
demand. Recent developments towards increasing sensitivity of SERS-based assays has been
focusing on improving the nanoparticle that are used as SERS-substrate [88].

SERS Substrates
SERS is a technique that involves the emission of radiation as a result of inelastic
scattering of incidence laser energy that impinges on the surface of a nanometallic object which
results in spectral peaks due to the vibrational modes of the molecule that are frequency shifted
from the incident energy.
SERS substrate is the metallic object on which the analyte molecule is adsorbed and
detected. Almost all polyatomic species exhibit Raman or SERS spectral emission. A typical
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example of SERS substrates are roughened silver, copper and gold surfaces. These SERS
substrates were in the form of colloids and foils/wires, however, recent development in the SERS
substrate reveal three main classifications, nanoparticle suspension, immobilized nanoparticle on
solid support and fabricated nanoparticle on substrates by special treatment such as lithography
synthesis. Several papers have demonstrated the use of these substrates for various applications.
Our focus is on the immobilization of metallic nanoparticles on a solid support and more
emphasis will be laid on immobilization on filter paper. Aggregation of spherical particle on a
solid support ensures maximum SERS enhancement [14] due to formation of SERS-hot spots.
Immobilization of the nanoparticles on a solid support provides a means of this aggregation.
Several immobilization strategies have been used to chemisorb nanoparticles on a solid support.
Recently, immobilization of substrates on paper methods have gained attention due to the high
flexibility, biocompatibility, biodegradability and low cost [50], and many papers have been
reported [50, 89]. For example, Fierro-Mercado et al, reported on a highly sensitive filter paper
substrate for SERS trace explosives detection [90]. In that work a thermal inkjet printer was used
to print colloidal nanoparticles onto filter paper.
The SERS signal enhancement is achieved by controlling the plasmonic properties and
morphology of the nanostructures that are used as SERS substrates. As such, significant efforts
are underway toward an architectural modification of the plasmonic particles with new methods
of fabrications to enhance SERS signal. This process is tedious and requires many steps and
therefore is time consuming that limits SERS application as a fast and cheap technique.
Therefore, the need to develop a rapid, sensitive and easy-to-use platform to detect biomarkers is
required to advance disease diagnostic arena for the management of disease.
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Paper-Based Assay (PBA)
The use of paper-based material as SERS substrates has gained much attraction toward
development of immunoassay due to the high flexibility, biocompatibility and cost effectiveness.
As such, three formats have been developed including LFA, dipstick assays, and microfluidic
paper based analytical devices (μPADs) [91].
The most common substrates that are used for the PBA are nitrocellulose membrane,
filter paper, chromatography paper, and or paper/nanomaterial composites [92]. The optical
properties and surface chemistry, as well as the porosity of these paper-based assays are very
essential in diagnostic application. Among these papers, the most widely used is nitrocellulose
membranes due to its broad distribution of pore sizes (0.05–12 μm) [8] for many proteins and
DNA applications. However, they have some limitation such as large accumulation of charges
under low humidity [93] which prevents its ease of use. The current limitation of the PBA needs
to be critically improved by signal enhancement strategies [94] as it is inappropriate for
diagnostic applications. Toward this end, the need of new methods to evade nonuniformity, poor
reproducibility and variable accuracy of PBA is required.

Thesis Objectives
The goal of this research is to develop a highly sensitive point-of-care system that is fast,
cheap and easy to use by anyone. Here we develop a new strategy through direct addition of
second gold nanoparticle layer on the plasmonic paper to create a new sensing environment that
would be able to enhance the SERS signal. The procedure has the advantage of simplifying the
assay procedure to less than 2 minutes and improves sensitivity of the assay by an order of
magnitude. This process overcomes the limitations of LFA.
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The system consists of an antibody-gold nanoparticle conjugate functionalized with a
Raman reporter molecule which is used to form a second layer on a modified antibody-AuNP
plasmonic filter paper after capturing antigen from a sample that vertically flows through the
plasmonic antibody-capture filter paper (Figure 7). The Raman reporter molecules provide a
vibrational spectrum that indicates the presence of antigen in the sample solution. They are
strategically designed to chemisorb as a thiolate adlayer on the gold nanoparticle, to provide a
strong and unique spectral signature, and to covalently link a layer of the antibody to the gold
nanoparticle. The vibrational spectrum resulting from the Raman reporter molecule is used to
trace and quantify any captured antigen from the flow through sample.

Figure 7. Overview of SERS VFA. Sample is applied and antigen is captured, ERL is applied to
labelled captured antigen then analyzed with SERS.
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CHAPTER II: MATERIALS AND METHODS
All materials, reagents and various analytical procedures for this research have been
explained in this chapter including various synthesis and physical measurements such as:
synthesis of gold nanoparticles for fabrication of plasmonic paper, preparation of the AuNPantibody conjugates and all analytical instruments used.

Materials and Reagents
Gold nanoparticles (AuNPs; 60 nm) were purchased from Ted Pella Inc. and used to
synthesis extrinsic Raman labels (ERLs). Bovine serum albumin (BSA), 4-nitrobenzenethiol (4NBT), Tween 20, and mouse IgG (I5381) were purchased from Sigma-Aldrich. Goat anti-mouse
IgG polyclonal antibody (ab 7063) was obtained from Abcam. Normal mouse serum was
acquired from Santa Cruz Biotechnology. Phosphate buffered saline (PBS; 10 mM, pH 7.4) and
sodium borate buffer (50 mM, pH 8.5) were purchased from Thermo Scientific. Whatman filter
paper grades 4 and 40 were used to prepare SERS substrate. A vertical flow device (Zoom Blot
Plate) and high capacity absorbing pads were purchased from Vitrozm.

Synthesis of Gold Nanoparticles (AuNPs)
AuNPs were synthesized and subsequently used to prepare plasmonic paper. Briefly, AuNPs
with □60 nm diameters were synthesized by the modified thermal reduction method [95, 96]. An
aliquot (2.0 mL) of gold solution (1 wt% HAuCl4·3H2O) was diluted to 100 mL with water in a 250
mL Erlenmeyer flask containing a magnetic stirring bar. After vigorously stirring the solution for 15
min, the flask was heated to boiling. Trisodium citrate (1 wt%; 1.5 mL) was quickly added to the
boiling solution, which led to the formation of spherical AuNPs. After completing the reaction, the

20

final solution was adjusted to 80 mL in total volume (exhibiting an extinction maximum of □2.4) and
stored at room temperature without further purification prior to use.

Preparation of Plasmonic Paper Capture Substrate
Whatman grade 4 and 40 filter paper with 8 and 25 µm pores sizes, respectively, were
selected to prepare the plasmonic paper capture substrate. Prepared AuNPs were embedded in
the two filter papers using a previously developed dipping method [97-100]. The papers were
first dried at 50 °C in an oven overnight and then immersed in 10 mL of the synthesized AuNP
suspension in a plastic petri dishes (60 mm x 15 mm). After soaking for 24 h, the filter papers
were removed from the AuNP suspension and completely dried in the oven (~40 °C) for 1 hr.
The resulting plasmonic paper was then cut into circles with a 3 mm diameter for use in the
SERS immunoassay. Unless noted otherwise, 2 µL of 1 mg/mL goat anti-mouse antibody was
applied to the 3 mm plasmonic paper substrate and dried in a desiccator for 1.5 h before use
[101].
Preparation of Extrinsic Raman Labels (ERLs)
Antibody and a Raman reporter molecule were co-adsorbed onto AuNPs to prepare
extrinsic Raman labels (ERLs), following a previously reported procedure [102, 103]. A 1.0 mL
aliquot of 60 nm AuNPs (Ted Pella, Inc.) was added to a microcentrifuge tube and 40 µL of 50
mM borate buffer (pH 8.5) was introduced to adjust the pH. Goat anti-mouse IgG antibody (30
µg) and 10 µL of 1 mM 4-NBT were added and incubated for 1 hour to allow the antibody and
4-NBT to adsorb onto the AuNPs, forming the ERLs. The ERL suspension was centrifuged at
5000g for 5 min and the supernatant above the pelleted ERLs was discarded to remove excess
antibody and 4-NBT that was not adsorbed to the AuNPs. The ERLs were resuspended in 2 mM
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borate buffer and the centrifugation/resuspension cycle was repeated two additional times. To the
purified ERLs, 10 µL of 10% BSA was added to further passivate any remaining surface on the
AuNPs and 10 µL of 10% NaCl was added to mimic physiological ionic strength and prevent
protein unfolding.
Vertical Flow Immunoassay Protocol
Calibration standards of the antigen were prepared by diluting a 1 mg/mL stock solution
of mouse IgG to final concentrations of 0.1, 0.5, 1, 10, 50, 100, 200, 300 and 400 ng/mL. Two
sets of calibration standards were prepared, one using PBS as the diluent and another using rabbit
serum as the diluent. PBS or rabbit serum served as the negative control to assess nonspecific
binding and specificity. The capture substrate, comprised of the plasmonic filter paper with preadsorbed goat anti-mouse IgG antibody, was then loaded on the adsorbing pad and inserted into a
vertical flow device. Once assembled, 1% BSA (100 μL) was added to the sample well, and
rapidly passed through the capture substrate into the absorbing pad to block the capture substrate
and sample well surface in an effort to prevent nonspecific binding. The sample solution, e.g.,
calibration standard or normal mouse serum, was then added to the sample well and antigen
molecules were captured on the plasmonic paper by the immobilized antibody as the solution
freely passed through the capture substrate. Next, ERLs were added to the sample well and
passed through the capture substrate to label any captured antigen, with excess ERLs drawn into
the absorbing pad. Excess ERLs were removed from the surface of the plasmonic paper by
passing a PBS rinse solution containing 5% Tween 20 through the paper. The plasmonic paper
was removed and allowed to dry in a desiccator before SERS analysis.
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Characterization Methods
The following sections provide details of characterization techniques and the detail of
procedures that were used to evaluate the performance of the assays, these include: Scanning
electron microscope (SEM), Surface enhanced Raman spectroscopy (SERS), Dynamic light
scattering (DLS) and Ultraviolet-visible spectroscopy.

Scanning Electron Microscope (SEM)
The plasmonic papers were examined using FEI-Quanta 450 SEM operating at 20 kV to
produced visual images of the papers. Prior to this analysis, the papers were coated with a thin
gold film using a Denton vacuum sputter coater (DESK II), to avoid common charging problems.
The images were collected to measure the general size distribution of plasmonic particles and to
visualize overall packing patterns of the NPs on the surface of the filter paper.

Surface Enhanced Raman Spectroscopy (SERS).
To evaluate SERS response of the vertical flow assay, SERS spectra were collected using
an Enwave Optronics, Inc. ProRaman-L-785B instrument configured with a 785 nm excitation
source set to 10 mW at the sample surface and a high-sensitivity CCD thermoelectrically cooled
to -60 °C. The sample was placed on an x-y-z sample stage and the laser was focused on the
substrate surface by maximizing the SERS intensity. After focusing the sample, the stage was
automated to move linearly along the x-direction during the 10 sec spectral acquisition as a
means of increasing the sampling area on the capture substrate, effectively averaging signal from
different locations on the substrate [104]. Five spectra were collected from each sample substrate
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and baseline corrected using the auto-baselin-2 algorithm built into the Enwave application
software (ProRaman Reader V8.2.8).

Dynamic Light Scattering (DLS)
The adsorption of the antibodies on the AuNPs of the ERL were confirmed by measuring
the mean hydrodynamic diameter and polydispersity of the AuNPs before and after the
preparation of the ERLs with a Malvern Zetasizer Nano ZSP. Unconjugated AuNP and
synthesized ERLS were diluted 2-fold with nano pure water and placed in a micro-volume
disposable Eppendorf cuvette for DLS analysis. The sample was equilibrated for 60 sec prior to
analysis and each size measurement was determined from 10 runs, 10 sec each.
UV-Visible Spectrometer
The synthesized gold nanoparticles used to prepare the plasmonic paper were
investigated to assess the number of AuNPs loaded on the filter paper by measuring the
extinction of the AuNP suspension before and after adsorption onto the filter paper. The UVvisible instrument used for this analysis was Agilent 8453 spectrophotometer (Agilent
Technologies, Santa Clara, CA). The instrument has a photodiode detector with a spectral range
of 190 -1100 nm. Prior to sample analysis the instrument was blanked with 2 mM borate buffer
(pH 8.5). The prepared plasmonic paper was also characterized using a surface UV-Vis-IR
spectrophotometer (300 – 1700 nm) equipped with a reflectance probe (StellarNet).
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CHAPTER III: RESULTS AND DISCUSSION
Assay Design and Sensing Principle
A general overview of the SERS-based vertical flow immunoassay is illustrated in Figure
8. Central to this platform is AuNP-loaded plasmonic paper, which serves as a capture substrate
for the detection of antigens. Antibody is pre-immobilized onto the plasmonic paper and antigen
is extracted and concentrated on the substrate as the sample solution passes through to an
absorbing pad via capillary action. In a second step, ERLs are spontaneously and vertically
passed through the plasmonic paper to specifically label captured antigen and facilitate SERSbased detection. The micron-sized pores in the filter paper allow any excess nanometer-sized
ERLs to rapidly and freely pass through the plasmonic paper to waste collected in the absorbent
pad. The plasmonic paper provides two key features. First, antibody irreversibly adsorbs onto
AuNPs embedded in the filter paper [105-108], to form a robust capture substrate that resists
desorption and loss of function while solutions flow through the paper. Second, the AuNP
embedded in the paper will form a sandwich-like structure with ERLs bound to captured antigen.
This architecture greatly supports plasmonic coupling between the AuNPs to generate a large
localized electric field between the sandwiched nanoparticles and significantly enhance the
SERS signal relative to the isolated ERL in the absence of plasmonic coupling [98, 109-112]. In
addition to the uniquely designed plasmonic paper to maximize analytical signal, the vertical
flow format overcomes diffusional mass transport limitations of traditional immunoassays to
substantially reduce assay time and does not suffer from the hook effect, as is the case for lateral
flow assays, to improve quantitative capabilities [45].
A model antibody-antigen system was employed to establish proof-of-principle for the
SERS-based LFA and illustrate the role of the plasmonic capture substrate. The plasmonic
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capture substrate and ERLs were both synthesized with goat anti-mouse IgG polyclonal antibody
and mouse IgG was employed as the antigen. The following sections detail the synthesis of the
plasmonic paper, the role of the plasmonic paper to facilitate large SERS enhancements, and the
assay parameters that impact analytical performance. After optimization, we defined the
analytical figures of merit and applied the protocol to accurately quantify IgG in normal mouse
serum.

Figure 8. Illustration of the SERS-vertical flow immunoassay protocol. In the first step, the
sample solution is vertically passed through the paper for antibody to extract the analyte. In the
second step, ERLs are passed through paper to label the captured antigen.
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Fabrication and Characterization of Plasmonic Paper
Filter paper loaded with spherical AuNPs serve as the foundation of the capture substrate
in the SERS-based vertical flow assay illustrated in Figure 8. Filter paper was selected because
of its numerous advantages such as affordability, accessibility, biodegradability, disposability,
modification, and variety of unique pore sizes. In this work, we selected Grade 4 and 40
Whatman filter paper with nominal pore sizes of 25 µm and 8 µm, respectively. Figure 9 shows
digital photographs of the two filter papers before and after loading with AuNPs, prepared by dip
coating [97-100]. The change in color of the filter paper from white to purple indicates the
adsorption of the AuNPs on the paper, and the consistent color across the full paper suggests
uniform distribution on a macroscopic scale. SEM images confirm adsorption of the AuNPs onto
the fibers of the filter paper with a mean diameter of 57.9 ± 12.5 nm. The images further reveal
small aggregates consisting of a few AuNPs are formed on the filter paper during the dip coating
process. Moreover, the SEM images show a greater loading density of AuNPs on the grade 4
filter paper than the grade 40 filter paper. The AuNP adsorption efficiency was quantified by the
changes of AuNP surface plasmon resonance (SPR) using UV-visible spectrophotometry. The
AuNP suspension exhibited an extinction of 2.4 at 540 nm before filter paper was dipped into the
suspension. After immersing the filter paper in the AuNP suspension for 24 h and subsequent
removal, the remaining suspension displayed an extinction of 0.7 and 1.3 for the grade 4 and 40
filter papers, respectively (Figure 9). These decreases in SPR bands represent the loading of 2.8
× 1011 AuNPs and 1.8 × 1011 AuNPs on the grade 4 and 40 filter papers, respectively.
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Figure 9. SEM images of plasmonic filter papers with their UV analysis of AuNPs solution of
grade number 4 and 40 with their corresponding UV analysis of before and after loading on the
papers.

To support the detectably, different amounts of plasmonic AuNP loading onto these two
papers, the surface UV-Vis-IR absorption patterns were obtained (Figure 10). Although
obtaining surface absorption patterns by a reflectance probe is somewhat difficult due to the light
absorbing characteristics of materials, the clearly different SPR patterns (i.e., broader SPR band
at 545 nm and increased background peak over 700 nm) explained that the grade 4 filter paper
possessed a relatively higher number of locally aggregated AuNPs than the grade 40 filter paper.
The presence of slightly more and dense packing of AuNPs could induce a higher probability of
effective plasmonic coupling that can favorably influence the degree of SERS enhancements.
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Figure 10. Surface UV-Vis-IR spectra of AuNPs loaded onto plasmonic papers of grade number
4 and 40 filter papers.

Role of Plasmonic Paper
SERS-based vertical and lateral flow immunoassays have been previously developed
using paper and nitrocellulose membranes as capture substrates. The goal of this work is to
capitalize on the benefit afforded by a plasmonic capture substrate to create sandwich-like
structures and achieve greater signal enhancements. To establish the value of the plasmonic
capture substrate, the vertical flow assay was performed using unmodified filter paper and
plasmonic filter paper. Antibody was deposited on unmodified filter paper and AuNP-embedded
filter paper to form the capture substrate [113, 114]. After blocking the paper with BSA, 100 µL
of the positive control sample (100 ng/mL of mouse IgG) was passed through the capture
substrate. The sample solution quickly passed through the unmodified filter paper and grade 4
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plasmonic paper in less than 10 sec; however, the 100 µL sample required more than 2 min to
flow through the grade 40 plasmonic paper. After allowing the sample to completely pass
through the capture substrate to the absorbent pad, 100 µL of ERLs were precisely applied to the
sample and allowed to pass through the capture substrate to label the antigen extracted by the
capture substrate. Again, the ERL flow rate was significantly faster through the grade 4
plasmonic paper than the grade 40 plasmonic paper. After rinsing the paper with PBS (100 µL),
SERS spectra were collected to quantify the bound antigen. Representative SERS spectra are
presented for each of the capture substrates in Figure 11. As is evident, the SERS signal is
characteristic of the Raman reporter molecule, 4-NBT, used to synthesize the ERLs, and include
prominent bands at 1338 cm-1 (symmetric NO2 stretch), 1559 cm-1 (C=C), 1153 cm-1 (C-O), and
850 cm-1 (C-H) [115, 116]. Importantly, the signal is markedly increased for the plasmonic paper
capture substrates relative to the capture substrate prepared with unmodified filter paper (Figure
11). Plasmonic paper resulted in ~4-fold and ~10-fold increase in signal for the capture substrate
prepared with grade 40 and grade 4 filter paper, respectively, relative to the unmodified paper.
Negative control samples were also analyzed to confirm that the signals obtained for the
mouse IgG sample was due to specific antibody-antigen interactions rather than non-specific
binding of the ERLs (e.g., physical adsorption) in the filter paper used as the foundation of the
capture substrate. To this end, PBS was passed through the capture substrates in the first step.
Subsequently, ERLs were passed through the capture substrates and analyzed via SERS (Figure
11). The signal measured for the PBS negative control was substantially lower than that observed
for the analysis of the positive control sample for each of the capture substrates. These results
confirm the specificity of antibody-antigen interaction yet reveal some non-specific binding of
the ERLs.
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Collectively, these results clearly demonstrate greater SERS signals are obtained for the
plasmonic capture substrates than the unmodified capture substrate. Interestingly, the plasmonic
paper fabricated with grade 4 filter paper provided greater signal for the analysis of the positive
control and lower signal for the analysis of the negative control sample than the grade 40 filter
paper. As indicated earlier, the SERS enhancement is as a result of interparticle coupling that
generates strong localized electromagnetic fields to maximize SERS signal from the substrate.
Our results suggest that SERS enhancement provided by the plasmonic capture substrate
corresponds to the number of plasmonic nanoparticles that are present on the surface of the
paper. Moreover, the paper with the bigger pore size, e.g., grade 4, resulted in less non-specific
binding of ERLs to generate less false-positive signal. Owing to this dual benefit, Whatman filter
paper grade number 4 was selected to prepare plasmonic capture substrates and optimize the
assay parameters.

Figure 11. SERS spectra collected using bare filter paper, plasmonic filter papers of grade 4
filter paper, and grade 40 plasmonic filter paper as the capture substrate in a SERS-RVF
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immunoassay. The positive control samples represent the analysis of 100 ng/mL mouse IgG and
the negative control samples represent the analysis of PBS.

Optimization of Assay Protocol
The following section explains the studies of the various assay parameters that enabled
achievement of the optimized conditions which focus on varying the amount of capture
antibodies, volume of ERLs and rinsing volume of PBS.

Amount of Capture Antibody
The ability to capture and concentrate antigen on the surface of the plasmonic paper as it
passes through correlates with the number of capture antibodies available on the substrate.
Therefore, the amount of the antibody deposited on the surface of the paper is an important
parameter that can contribute to the analytical performance of the vertical flow immunoassay.
Ideally, sufficient antibody is added to the plasmonic paper to saturate all available
immobilization sites. However, addition of a large excess of antibody must be avoided to
minimize the cost of the assay. To this end, goat anti-mouse IgG antibody (1 to 4 μg) was
deposited on plasmonic paper (grade 4) to prepare capture substrates with variable amounts of
capture antibody. A positive control sample (100 ng/mL antigen) and negative control sample
(PBS) were analyzed with each capture substrate, using 100 µL of ERLs and 100 µL of PBS for
subsequent labeling and rinsing, respectively. The SERS signal as a function of the amount of
capture antibody is plotted for the positive and negative samples in Figure 12a. The positive
control signal increased as the amount of deposited capture antibody increased from 1 to 2 µg;
however, no further increase was observed for the positive control sample with the deposition of
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more than 2 µg of capture antibody. The signal for the negative control sample was independent
of the mass of capture antibody immobilized on the capture substrate. Based on the results of this
experiment, 2 μg of capture antibody was selected for cost effectiveness, since this mass
provided enough antibodies to effectively maximize the capture of antigen in a 100 ng/mL
sample and produce a maximum SERS signal.
To understand the activity of these capture antibodies, a paper to paper variability
analysis was conducted which are shown in Figures 12b and 12c. Each bar represents average
intensity of five SERS spectra collected from five different location on the paper with error bars.
The results of the two papers show the same trend with statistically equivalent SERS intensities.
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Figure 12. Effect of the amount of capture antibody on plasmonic filter paper grade number
4. obtained by varying the mass of the capture antibody to capture 100 ng/mL mouse IgG,
with subsequent labelling and rinsing using 100 μL of ERLs and 100 μL of PBS. (a) positive
and negative control samples (b) plasmonic paper 1 (c) plasmonic paper 2.
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Volume of Extrinsic Raman Labels (ERLs)
The effect of ERL volume on SERS intensity was investigated to maximize the analytical
signal by ensuring all the captured antigen was labelled. Plasmonic paper was loaded with 2 µg
of capture antibody to prepare the capture substrate. A positive control sample (100 ng/mL
antigen) or a negative control sample (PBS) was passed through the capture substrate followed
by varying volumes of ERLs (25, 50, 100, and 200 µL) to label the capture antigens. After
rinsing with 100 µL of buffer SERS spectra were collected, and the average intensities are
plotted as a function of ERL volume in Figure 13a. The SERS signal increases as the ERL
volume increases from 25 to 100 µL, suggesting that <100 µL of ERLs is insufficient to label all
of the captured antigen for a sample concentration of 100 ng/mL. While there was a slight
increase in the mean signal when the ERL volume increased from 100 to 200 µL the difference
was not statistically different at the 95% confidence level; thus, indicating that 100 mL of ERLs
was sufficient to label all antigens captured on the substrate for the 100 ng/mL sample. It is
worth noting that analysis of samples with a concentration greater than 100 ng/mL may result in
more captured antigens and therefore require a greater ERL volume to fully label all antigen
molecules. Importantly, the signal of the negative control samples did not statistically differ
among any of the ERL volumes tested. Therefore, based on the parameters used in this
optimization study, 200 µL of ERLs were considered optimized and used for subsequent assays.
To understand the activity of the ERL, a paper to paper variability analysis were
conducted which are shown in Figure 13b and 13c. Each bar represents average intensity of five
SERS spectra collected from five different location on the paper with error bars. The results of
the two papers shows the same trend with statistically equivalent SERS intensities.
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Figure 13. Effect of ERL volume on SERS intensity of plasmonic papers grade number 4
capture substrate. Obtained using 2 μL of 1mg/ml anti-goat mouse IgG, 100 ng/ml of mouse
IgG and 50 μL of PBS rinsing volume with variable ERL volumes. (a) positive and negative
control samples (b) Paper 1 (c) Paper 2.

Volume of Rinsing Buffer
We investigated the effect of rinsing volume in an effort to minimize non-specific
binding. In this study, positive (100 ng/mL antigen) and negative (PBS) were analyzed by the
vertical flow assay using the optimized mass of capture antibody (2 μg) and volume of ERLs
(200 μL). Following the labeling step, different volumes of the rinsing buffer were applied to the
sample well and passed through the capture substrate to remove non-specifically bound ERLs.
Figure 14a plots the SERS intensities for the negative samples as a function of rinse buffer
volume. The signal for the negative control sample is a measure of the non-specific binding, and
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the data show that the negative control signal decreases as the volume of rinse buffer increases
from 50 to 200 μL. That data clearly shows that excess unbound ERLs remain in the capture
substrate filter paper when the rinse volume was less than 200 μL. An increase to 400 μL of PBS
rinsing buffer did not lead to a further reduction in the background signal. Figure 14a (inset)
plots the signal collected for the positive control samples as a function of PBS rinsing volume.
The data show a decrease in the signal for the positive control sample as the rinse volume
increases from 50 to 100 µL, which is likely due to the removal of excess unbound ERLs. The
positive control signal is independent of rinse volumes between 100 and 400 µL, which suggests
that these volumes do not disrupt the specific antibody-antigen interactions. Based on the
assessment of these results, we selected 300 µL of rinsing volume for subsequent optimized
assays. This volume of rinsing buffer ensures a thorough removal of excess, non-specifically
bound ERLs and maintains the maximum analytical signal, while balancing the assay time.
Larger volumes require more time for the buffer to pass through the capture substrate, and it is
noteworthy that the flow rate decreases as the absorbent pad becomes saturated with liquid.
To understand the activity of the rinsing buffer, a second sample was analyzed using
different prepared plasmonic paper with same rinsing volume variation and the same conditions
and the results are plotted in Figure 14b. Each bar represents the average intensity of five SERS
spectra collected from five different locations on the paper with error bars.
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Figure 14. Effect of PBS rinsing volume on SERS intensity of capture substrate. Obtained
using 2 μL of 1 mg/mL anti-goat mouse IgG, 100 ng/mL of mouse IgG, 200 μL ERL volumes
with variable PBS rinsing volume. (a) SERS intensity as a function of rinsing buffer (b)
Average SERS intensity as a function of rinsing buffer second experiment.
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Analytical Performance – Dynamic Range, Detection Limit, Reproducibility,
Selectivity
The analytical performance of the assay was evaluated using the optimized conditions to
generate a calibration curve for the analysis of mouse IgG and establish the dynamic range,
detection limit, and reproducibility. Three assays for mouse IgG were performed on three
different weeks using three independently prepared suspensions of ERLs and three
independently prepared sets of plasmonic paper. Raman spectra illustrating the positive and
negative controls are shown in Figure 15.

Figure 15. Illustration of SERS spectra of positive and negative control samples.

A calibration curve was generated for each independent assay to allow for analysis of
intra- and inter-assay reproducibility. Concentration-dependent SERS spectra are presented in
Figure 16 for one calibration dataset.
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Figure 16. SERS spectra of concentration dependent assay. Obtained using optimized
conditions and varying the concentration of the mouse IgG in ng/mL.

As is evident, the SERS intensity increases with a corresponding increase in antigen
concentration. The most intense band at 1338 cm-1, due to the symmetric nitro stretch, is plotted
as a function of antigen concentration to generate a calibration curve (Figure 17). Each data point
represents the average signal collected from five different locations across the capture substrate
and the error bars represent the standard deviation. The spot-to-spot variation in analytical signal
measured 10-20% for most samples, although at low concentrations, e.g., 0.5 ng/mL, where the
signal was small, it varied as much as 37%.
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Figure 17. Calibration curve of the VFA obtained using the optimized conditions with limit of
detection.

Calibration plots for two additional independent assays (assay 2 and assay 3) are
presented in Figure 18. Critical analysis of the raw signals to evaluate the inter-assay reveals that
the percent relative standard deviations (%RSD) are 10-30% for a given concentration. Closer
inspection of the calibration plots shows that each dataset has a similar plot, in which the signal
increases for sample concentrations between 0 and 100 ng/mL before reaching a maximum
signal as the capture substrate becomes saturated at concentrations greater than 100 ng/mL. Each
of the three independent assays shows a slightly different maximum signal at saturation. While
the dynamic range and overall curve shape, i.e., biding behavior, is similar for each assay, the
differences in maximum signal are attributed to differences in the synthesized plasmonic paper
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substrates responsible for the SERS enhancement. To support this claim, we recently found
~20% variability in SERS signals collected from plasmonic papers [98].

To account for the differences in plasmonic paper enhancement, each calibration curve
was normalized with respect to its maximum signal (Figure 19). After normalization to account
for substrate differences the inter-assay variability was significantly reduced to ~10-20%.

Figure 18. Calibration plots for absolute averaged intensity of three independent assays.
Obtained by plotting absolute average intensity as a function of concentration of mouse IgG in
ng/mL using the optimized condition.
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Figure 19. Calibration plots for normalized averaged intensity of three independent assays.
Obtained by plotting normalized intensity as a function of concentration of mouse IgG in
ng/mL using the optimized condition.

The detection limit of the SERS vertical flow assay was defined as the antigen
concentration that produces a signal equal to the blank signal plus three times the standard
deviation of the blank measurement. The calibration data presented in Figure 17 was best fit to a
ligand binding model, i.e., saturation curve (Equation 1) [117],
𝑦𝑦 =

𝐵𝐵𝑚𝑚𝑚𝑚𝑚𝑚 𝑥𝑥
𝐾𝐾𝑑𝑑 +𝑥𝑥

(1)

where Bmax represents the maximum binding, i.e., maximum signal, and Kd is the
antibody-antigen dissociation constant. Based on the best fit of the data, and replicated signals
acquired for the blank, the detection limit was 3 ng/mL. Similar evaluation of the two additional
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independent calibration datasets presented in Figure 18 resulted in detection limits of 8 and 3
ng/mL. This detection limit is equivalent to that obtained for a solution based assay we
previously reported using a similar antibody-antigen system, yet this current platform does not
suffer from the hook effect [102]. Moreover, a filter based immunoassay using a syringe to
facilitate flow rather than a vertical flow-based absorbent pad yielded a detection limit of 1-10
ng/mL for mouse IgG, but required 1 mL of sample and 10 minutes to complete the assay rather
than the 100 µL of sample and ~2 min assay time required for this current format [118]. It is
worth noting that other vertical flow assays without a plasmonic capture substrate have reported
lower detection limits than we present here [101, 119, 120]; however, those works employed
monoclonal antibodies, and it is well-established that the binding affinity of the antibody-antigen
governs the detection limit; thus, we can only compare to other studies that used goat anti-mouse
IgG polyclonal antibodies as a model system.
In an effort to determine the effect of sample matrix on the assay performance,
calibration standard solutions of mouse IgG antigen were prepared in PBS and in 10% rabbit
serum. The calibration curves generated with each of these solvents are overlaid in Figure 20.
Similar calibration curves are obtained for each of these sample matrices and provide two key
findings. First, these results confirm that the assay can capture the antigen protein in the presence
of a complex biological matrix. Second, this experiment validates the specificity of the
immunoassay given that rabbit serum contains a large concentration of rabbit IgG which is not
detected by the anti-mouse IgG capture substrate and ERLs.
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Figure 20. Calibration plots of mouse IgG prepared in PBS and 10% rabbit serum.

Application of the SERS-VFA to the Analysis of Mouse Serum
Based on these encouraging results, we then applied our SERS-VFA to determine the
concentration of mouse IgG in mouse serum. IgG is an abundant protein found in serum and has
normal concentration range of 5-13 mg/mL in serum collected from healthy mice. Given that the
concentration of mouse IgG in normal serum is outside of the limit of linearity (Figure 17) for
the SERS-VFA, the mouse serum was diluted 1:106 using PBS as a diluent. We prepared three
independent mouse serum samples (unknown A, B and C, Table 2) and the diluted serum
samples were analyzed using a newly prepared set of plasmonic paper capture substrates.
Concurrently, the capture substrates were used to analyze mouse IgG standards to generate a
calibration curve. (Table 1 and Figure 16). The IgG concentration in the diluted serum measured
11 ± 3 ng/mL, based on the best fit of the calibration data to the ligand binding curve, which
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translates to an IgG concentration of 11 ± 3 mg/mL in the original undiluted mouse serum
sample. This experimental IgG concentration in normal mouse serum is in the expected range
and is consistent with measured values for mouse IgG in normal serum.
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Figure 21. Calibration curve to determine IgG in mouse serum obtained using optimized
condition.
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Figure 22. Limit of linearity of the calibration curve.

Table 1. Mouse IgG (mIgG) Diluted in PBS.
mIgG (ng/mL)
0

Mean SERS
Intensity (cts)
455 ± 99

0.1

475 ± 94

0.5

550. ± 49

1

655 ± 92

10

1194 ± 118

50

3163 ± 241

100

6138 ± 304

200

6417 ± 532

400

7164 ± 468
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100

120

Table 2. Average SERS intensity of diluted mouse serum.
Unknown
(ng/mL)

Averaged
SERS intensity

A

577 ± 62

B

683 ± 89

C

1660 ± 98
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CHAPTER IV: CONCLUSION AND FUTURE WORKS
Research Summary
Over the past decades, the point-of-care diagnostic platform has become an integral part
of medicine and environmental analysis due to the benefit of instant results. The current POCT
that has obtained commercial success is the LFA. Despites the many advantages of these
techniques, they also have limitations. Latera flow devices can produce instant results; however,
they cannot be applied for an accurate quantification analysis. Moreover, LFAs suffer from a
high rate of false negative results. These challenges result in inaccurate results and therefore
limits its full potential in biomedical applications.
Gold nanoparticle-protein conjugation has become an active area of research due to the
selective nature of antibody-based assays, biocompatibility and excellent optical properties of
gold nanoparticles. There are many existing methods demonstrating various ways of
immobilizing proteins on gold nanoparticles with the majority of them focused on the electronic
and covalent interaction between the gold nanoparticle and proteins. Many point-of-care
techniques take advantage of these to improve the current methods of detection. One area that
has gained much attention is surface enhanced Raman spectroscopy (SERS) due to its unparallel
sensitivity for single molecule detection. Recently, SERS-based immunoassays have become an
active area of research and many researchers are coupling SERS with the current methods (e.g
LFA) to improve sensitivity, quantification and analysis time.
In this work, we developed a SERS-based rapid vertical flow assay employing plasmonic
paper as the capture substrate. Using mouse IgG as a model antigen, we established a novel
strategy to promote a significant signal enhancement for SERS detection by AuNP-embedded
filter paper compared to previously utilized paper-based substrates. Our approach takes
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advantage of the plasmonic coupling between the underlying plasmonic capture substrate paper
and the nanoparticle labels, e.g., ERLs, to generate exceedingly large signals. Moreover, the
vertical flow format enables the capture and concentration of analyte from a small volume of
sample for rapid detection using capillary action to actively transport the sample through the
capture substrate to overcome diffusion limited mass transport. Lastly, the vertical flow approach
is not complicated by the hook effect for the analysis of highly concentrated samples. The ease
of use, speed of analysis, low detection limits, and low cost of components suggest this assay is
poised to meet the demands of point-of-care diagnostic testing, on-site environmental analysis,
and point-of-need biodefense applications.
The summary of the results obtained during this study are briefly explained according to
the following sections:
Section A: Optimized assay parameters
Section B: Analytical performance of the SERS-VFA
Section C: Application of the SERS vertical flow assay for determination of IgG
concentration in mouse serum.

Section A: Optimization of Assay Parameters
Development of assay protocols for an accurate and reliable testing platform requires an
optimized system that is reproducible. The first part of this research was to obtain an optimized
system that enabled maximum performance of the assay. The parameters we investigated in this
analysis were the effect of antibody on the capture substrate, the effect of ERL volume and the
volume of the rinsing buffer. The quantities of these parameters have a significant impact on the
assay results and therefore must be carefully controlled.
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As an initial step, we first optimized the amount of antibodies deposited on the plasmonic
paper. The antibodies were strategically immobilized on the plasmonic papers to control the
binding sites; this determined how much antibody was available on the plasmonic paper to
capture the antigen upon passing the sample through the paper in order to bind to the ERL. We
determined that the SERS signal response is dependent on the number of antibodies available on
the surface of the paper to antigen molecules. As the number of antibodies increased the SERS
signal intensity increased due to the higher number of antigens that were captured until excess
antibodies were available to bound all antigen molecules.
The effect of ERL volume on SERS intensity was investigated to determine if the amount
of binding, e.g ERL-antigen complex was mass dependent. The quantity of the ERLs available
on the surface of the membrane determines the intensity of the SERS signal which was used to
quantify amount of antigen captured from the flowing sample. Again, we determined that the
volume of the ERL was directly proportional to the SERS signal intensity and that surface
saturation occurs at the maximum volume where all captured antigens have become bound with
the ERL.
The nonspecific bindings of ERL can result to false positive results and therefore must be
minimized. This was done using PBS rinsing buffer that contains surfactants. We concluded that
as the rinsing volume increases the negative control signal decreases however excess volume can
marginalized the assay results and therefore must be controlled.

52

Section B: Analytical Performance of the SERS-VFA
The second part of this thesis was to demonstrate the capability of our developed SERSbased vertical flow assay by determining the dynamic range, limit of detection, selectivity and
reproducibility. A calibration curve was generated, and the dynamic range was established
between 1 -100 ng/mL, while saturation occurs at greater antigen concentrations. The spot-tospot variation of the paper was found to be ~ 10-20% which is comparable to available evidence
of SERS signal collected from plasmonic paper. The calibration curve was fitted to a ligand
binding curve and determined the limit of detection to be 3 ng/mL which is equivalent to a
solution-based assay we previously developed using the same antigen-antibody system. In
addition, our developed system uses minimal sample volume of 100 µL and less time of 2 mins
which is better than our previous methods which require 1 mL of sample solution and 10 mins
for analysis. We were able to establish the selectivity of our system by generating a calibration
curve using mouse IgG prepared in 10% rabbit serum which is similar to that prepared in the
PBS.

Section C: Application of the SERS-VFA to Determine IgG in Mouse Serum
Our vertical flow assay was used to investigate the concentration of mouse IgG in normal
mouse serum to evaluate the quantitative capability of the technique. The mouse serum which
has high concentration of mouse IgG (5 -13 mg/mL) falls outside the limit of linearity of our
SERS VFA. By a million times dilution of the serum followed by SERS analysis the amount of
mouse IgG present in the serum was accurately determined.
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Future Works
One avenue of future work will include extending our current SERS-based detection
strategy to applications involving simultaneous multiplexed detection. The use of ERLs prepared
using different antibodies and Raman labels allowed simultaneous detection of different
biomarkers by first immobilizing two different types of capture antibodies on the plasmonic
paper. A sample with the potential to contain two antigens would then pass through the
plasmonic capture substrate and each antigen would be extracted by its respective antibody. The
mixed ERLS would then be used to label captured antigens. The unique SERS spectra of each
Raman label would then be used to identify the presence and quantity of each antigen
independently.
A second avenue worthy of exploration is the plasmonic system. In this SERS RVF
assay, spherical gold nanoparticles are embedded in the paper substrate and spherical gold serves
as the core of the ERL. We have recently shown that sandwiched structures of different
plasmonic nanoparticles can lead to better plasmonic coupling and SERS enhancement than the
AuNP-AuNP system used to develop this assay. In this work miRNA was sandwiched between a
silver nanoparticle and anisotropic gold nanoparticle. As is evident in ref [61], SERS response of
the miRNA sandwiched between a silver nanoparticle and anisotropic gold nanoparticle was
substantially greater than miRNA sandwiched between two spherical AuNPs. These results
suggest our plasmonic capture substrate should be prepared with anisotropic gold particles and
the ERLs should consist of a silver nanoparticle core for even greater enhancement. In addition,
exploring different plasmonic particles, we also plan to apply a third layer of these different
types of nanostructures to potentially increase the sensitivity of the SERS-VFA. In our
preliminary work we analyzed samples by applying a third layer of concave cube solution of
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AuNP to a sandwiched mouse IgG between two spherical AuNPs. The SERS response in the
third layer analysis shows greater enhancement than that between the sandwiched system as
evidenced in Figure 18. This result also demonstrates the capability of the concave cube gold
nanoparticle to be used as ERL and plasmonic paper to increase the sensitivity of the SERSVFA.

35000
Pos before 3rd layer
Pos after 3rd layer

SERSintensity @ 1336 cm-1 (10 s cts)

30000

Neg before 3rd layer

25000

Neg after 3rd layer

Figure 23. SERS spectra of concave cube AuNPs solution 3rd layer analysis of mouse IgG.
Obtained using 10 µg/ml mouse IgG with the optimized conditions of the SERS–VFA.
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